Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.
Samuel R Friedman, Wouter de Jong, Diana Rossi...
https://pubmed.ncbi.nlm.nih.gov/17689353Actively Recruiting
Led by University of Pennsylvania · Updated on 2026-02-27
390
Participants Needed
3
Research Sites
17 weeks
Total Duration
U
University of Pennsylvania
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
Researchers are evaluating a peer-led health resilience and promotion program called the THRIVE intervention for people with opioid use disorder. The study aims to find out if participants receiving the THRIVE intervention have fewer self-reported non-fatal overdoses or skin and soft tissue infections compared to those receiving enhanced usual care. The study is sponsored by the University of Pennsylvania and focuses on support following hospital discharge. Participants in the THRIVE intervention group will receive one in-person session from a peer support specialist while in the hospital, followed by weekly text messages for 12 weeks. They will also answer monthly multiple-choice assessments via text at months 1 through 6. Participants in the enhanced usual care group will receive a handout with health resilience education and local resources and will complete the same monthly text assessments. Both groups will complete baseline, 3-month, and 6-month assessments with research assistants. Throughout the study, participants will be monitored through self-reported surveys and assessments to track the incidence of non-fatal overdoses and skin or soft tissue infections. The primary outcome compares these outcomes from baseline to 6 months between the two groups. Participants will be evaluated at multiple time points, with data collected via text messages and in-person assessments, allowing researchers to measure the effectiveness of the THRIVE intervention over half a year.
CONDITIONS
Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive either a peer-led, in-person session with weekly text message support over 12 weeks or enhanced usual care through educational handouts.
1 in-person session and weekly text messages over 12 weeks
Duration - Up to 6 months
Participants are monitored for health outcomes including incidence of non-fatal overdoses and skin and soft tissue infections up to 6 months.
Visits as scheduled for outcome assessments
Total: 3 locations
1
UPMC Mercy Hospital
Pittsburgh, Pennsylvania, United States, 15203
Not Yet Recruiting
2
UPMC Presbyterian-Montefiore Hospital
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
3
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania, United States, 15232
Not Yet Recruiting
R
Research Program Coordinator
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Samuel R Friedman, Wouter de Jong, Diana Rossi...
https://pubmed.ncbi.nlm.nih.gov/17689353Bernadette Bernie Pauly, Dan Reist, Lynne Belle-Isle...
https://pubmed.ncbi.nlm.nih.gov/23623720Bernadette Pauly
https://pubmed.ncbi.nlm.nih.gov/18226520Michael D Stein, Kristina T Phillips, Debra S Herman...
https://pubmed.ncbi.nlm.nih.gov/32830383Kristina T Phillips, Catherine Stewart, Bradley J Anderson...
https://pubmed.ncbi.nlm.nih.gov/33677353Amina Moustaqim-Barrette, Damon Dhillon, Justin Ng...
https://pubmed.ncbi.nlm.nih.gov/33771150Rebecca McDonald, John Strang
https://pubmed.ncbi.nlm.nih.gov/27028542Maxwell S Krieger, Jesse L Yedinak, Jane A Buxton...
https://pubmed.ncbi.nlm.nih.gov/29422052Susan G Sherman, Kenneth B Morales, Ju Nyeong Park...
https://pubmed.ncbi.nlm.nih.gov/30991301Jacqueline E Goldman, Katherine M Waye, Kobe A Periera...
https://pubmed.ncbi.nlm.nih.gov/30621699